Elimination of Human Papillomavirus and Cervical Pathological Microbiota with Photodynamic Therapy in Women from Mexico City with Cervical Intraepithelial Neoplasia I
- PMID: 36773299
- DOI: 10.1111/php.13791
Elimination of Human Papillomavirus and Cervical Pathological Microbiota with Photodynamic Therapy in Women from Mexico City with Cervical Intraepithelial Neoplasia I
Abstract
Cervical carcinoma (CC) is the second cause of cancer death in Mexican women. It starts with premalignant lesions known as Intraepithelial Cervical Neoplasia (CIN) that can develop due to infection by Human Papillomavirus (HPV) and other microorganisms. Current CIN therapy involves invasive methods that affect cervix integrity and fertility; we propose the use of photodynamic therapy (PDT) as a strategy with few side effects. In this work, the effectiveness of PDT for CIN I, HPV and pathogenic vaginal microbiota elimination in 29 women of Mexico City with CIN I, CIN I + HPV and HPV diagnosis was determined. After 6 months of PDT application, HPV infection was eliminated in 100% of the patients (P < 0.01), CIN I + HPV in 64.3% (P < 0.01) and CIN I in 57.2% (P > 0.05). PDT also eliminated pathogenic microorganisms: Chlamydia trachomatis in 81% of the women (P < 0.001) and Candida albicans in 80% (P < 0.05), without affecting normal microbiota since Lactobacillus iners was eliminated only in 5.8% of patients and the opportunistic Gardnerella vaginalis in 20%. These results show that PDT was highly effective in eradicating HPV and pathogenic microorganisms, suggesting that PDT is a promising therapy for cervical infections.
© 2023 American Society for Photobiology.
Similar articles
-
Evaluating photodynamic therapy protocols for high-grade cervical neoplasia: A comparative study.Photodiagnosis Photodyn Ther. 2025 Jun;53:104603. doi: 10.1016/j.pdpdt.2025.104603. Epub 2025 Apr 22. Photodiagnosis Photodyn Ther. 2025. PMID: 40273965 Clinical Trial.
-
Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: A systematic review and meta-analysis of randomized clinical trials.Medicine (Baltimore). 2018 May;97(21):e10864. doi: 10.1097/MD.0000000000010864. Medicine (Baltimore). 2018. PMID: 29794788 Free PMC article.
-
Characterization of human papillomavirus genotypes infections in patients with cervical lesions and cervical cancer in Urumqi, Xinjiang from 2016 to 2023.Virol J. 2025 Mar 13;22(1):72. doi: 10.1186/s12985-025-02674-1. Virol J. 2025. PMID: 40082961 Free PMC article.
-
Evaluation of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for cervical intraepithelial neoplasia with human papillomavirus (HPV) infection: a retrospective comparative study versus loop electrosurgical excision procedure (LEEP).Photodiagnosis Photodyn Ther. 2025 Aug;54:104697. doi: 10.1016/j.pdpdt.2025.104697. Epub 2025 Jun 26. Photodiagnosis Photodyn Ther. 2025. PMID: 40581201 Review.
-
Efficacy of ALA-PDT in treating cervical low-grade squamous intraepithelial lesions with high-risk HPV patients: A multicentre randomized controlled trial.Int J Cancer. 2025 Sep 1;157(5):908-915. doi: 10.1002/ijc.35450. Epub 2025 Apr 23. Int J Cancer. 2025. PMID: 40268556 Clinical Trial.
Cited by
-
Emerging trends and hotspots in cervical intraepithelial neoplasia research from 2013 to 2023: A bibliometric analysis.Heliyon. 2024 May 29;10(11):e32114. doi: 10.1016/j.heliyon.2024.e32114. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38882369 Free PMC article.
References
REFERENCES
-
- World Health Organization. Cervical cancer Mexico 2021 country profile. Available at: https://www.who.int/publications/m/item/cervical-cancer-mex-country-prof.... Accessed on June 30, 2022.
-
- Jin, Z., G. Zhong, W. Qiang, S. Tianbin, P. Shuyan, W. Chenjing, Q. Hongmie, Z. Jianbin, M. Ying, N. Cong and Z. Dan (2017) Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan China. Infect. Agent Cancer 12, 8.
-
- Novikova, T. (2017) Optical techniques for cervical neoplasia detection. Beilstein J. Nanotechnol. 8, 1844-1862.
-
- Correa, R. M., A. Baena, J. Valls, M. C. Colucci, L. Mendoza, M. Rol, C. Wiesner, A. Ferrera, M. D. Fellner, J. V. González, J. A. Basiletti, P. Mongelos, M. Rodríguez, A. de la Peña, E. K. Saino, C. Velarde, N. Macavilca, S. Martinez, G. Venegas, A. Calderón, G. Rodriguez, H. Barrios, R. Herrero, M. Almonte and M. A. Picconi (2022) Distribution of human papillomavirus genotypes by severity of cervical le-sions in HPV screened positive women from the ESTAMPA study in Latin America. PLoS One 17, 7.
-
- Doorbar, J. and H. Griffin (2019) Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Res. 7, 176-179.